global glp-1 obesity drug market size forecast 2030 GLP-1 Drug Market: the rapid

Could this drug made for type 2 diabetes be a game changer for heart disease too

Among those who have been diagnosed with diabetes, 14.1% report using these drugs for weight loss purposes, slightly higher than the general adult population

[PubMed] [Google Scholar] 85.Han V.K., Hynes M.A., Jin C., Towle A.C., Lauder J.M., Lund P.K

The GLP-1 receptor is expressed in the gut, pancreas, brainstem, hypothalamus and vagal afferent nerves [35]

The advancement of economical manufacturing procedures and biosimilars is an urgent need

1 Factors that will affect the choice of the second agent include patient preference, cost, potential adverse effects, impact on weight, efficacy, and risk of hypoglycemia